Can we safely reduce blood loss during lumbar pedicle subtraction osteotomy procedures using tranexamic acid or aprotinin?

Spine

Volumn 35, Issue 2, 2010, Pages 235-239

  Baldus, Christine R ^a   Bridwell, Keith H ^a   Lenke, Lawrence G ^a   Okubadejo, Gbolahan O ^b  

^a WASHINGTON UNIVERSITY   (United States)

^b Active Joints Orthopedics   (United States)

Author keywords

Aprotinin; Pedicle subtraction osteotomy; Tranexamic acid

Indexed keywords

APROTININ; TRANEXAMIC ACID;

ACUTE KIDNEY TUBULE NECROSIS; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLEEDING; BLOOD VOLUME; BONE GRAFT; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COMORBIDITY; CONTINUOUS INFUSION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HEART INFARCTION; HEMATOCRIT; HEMOSTASIS; HUMAN; LOADING DRUG DOSE; LUMBAR PEDICLE SUBTRACTION OSTEOTOMY; LUNG EMBOLISM; MALE; OPERATION DURATION; OSTEOTOMY; PRIORITY JOURNAL; SEIZURE; SEX DIFFERENCE; SPINE FUSION; SURGICAL PATIENT; SURGICAL TECHNIQUE;

ADULT; AGED; ANTIFIBRINOLYTIC AGENTS; APROTININ; BLOOD LOSS, SURGICAL; FEMALE; HEMOSTATICS; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOTOMY; RETROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 77749299020     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3181c86cb9     Document Type: Article

References (24)

1. Lentschener C, Cottin P, Bouaziz H, et al. Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion. Anesth Analg 1999;89:590-7.
2. Urban MK, Beckman J, Gordon M, et al. The efficacy of antifibrinolytics in the reduction of blood loss during complex adult reconstructive spine surgery. Spine 2001;26:1152-7.
3. Cho K, Bridwell K, Lenke L, et al. Comparison of Smith-Petersen versus pedicle subtraction osteotomy for correction of fixed sagittal imbalance. Spine 2005;30:2030-7.
4. Despotis GJ, Avidan MS, Hogue CW Jr. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg 2001;72:1821-31.
5. Bridwell K, Lewis S, Edwards C, et al. Complications and outcomes of pedicle subtraction osteotomy for fixed sagittal imbalance. Spine 2003;28: 2093-101.
6. Wang MY, Berven SH. Lumbar pedicle subtraction osteotomy. Neurosurgery 2007;60:140-4.
7. Khoshhal K, Mukhtar I, Clark P, et al. Efficacy of aprotinin in reducing blood loss in spinal fusion for idiopathic scoliosis. J Pediatr Orthop 2003;23: 661-4.
8. Samama CM, Langeron O, Rosencher N, et al. Aprotinin versus placebo in major orthopedic surgery: a randomized, double-blinded, dose-ranging study. Anesth Analg 2002;95:287-93.
9. Murkin JM, Haig GM, Beer KJ, et al. Aprotinin decreases exposure to allogenic blood during primary unilateral total hip replacement. J Bone Joint Surg Am 2000;82:675-84.
10. Capdevila X, Calvet Y, Biboulet P, et al. Aprotinin decreases blood loss and homologous transfusions in patients undergoing major orthopedic surgery. Anesthesiology 1998;88:50-7.
11. Cole JW, Murray DJ, Snider RJ, et al. Aprotinin reduces blood loss during spinal surgery in children. Spine 2003;28:2482-5.
12. Kasimian S, Skaggs DL, Sankar WN, et al. Aprotinin in pediatric neuromuscular scoliosis surgery. Eur Spine J 2008;17:1671-5.
13. Okubadejo GO, Bridwell KH, Lenke LG, et al. Aprotinin may decrease blood loss in complex adult spinal deformity surgery, but it may also increase the risk of acute renal failure. Spine 2007;32:2265-71.
14. Tayyab NA, Mariller MM, Rivlin M, et al. Efficacy of aprotinin as a blood conservation technique for adult deformity spinal surgery: a retrospective study. Spine 2008;33:1775-81.
15. Mangano DT, Tudor IC, Dietzel C; Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006;354:353-65.
16. Mangano DT, Miao Y, Vuylsteke A, et al; Investigators of the Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 2007;297:471-9.
17. Hardy JF, Desroches J. Natural and synthetic antifibrinolytics in cardiac surgery. Can J Anaesth 1992;39:353-65.
18. Neilipovitz DT, Murto K, Hall L, et al. A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anesth Analg 2001;93:82-7.
19. Sethna NF, Zurakowski D, Brustowicz RM, et al. Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology 2005;105:727-32.
20. Shapiro F, Zurakowski D, Sethna NF. Tranexamic acid diminishes intraoperative blood loss and transfusion in spinal fusions for Duchenne muscular dystrophy scoliosis. Spine 2007;20:2278-83.
21. Wong J, El Beheiry H, Rampersaud YR, et al. Tranexamic acid reduces perioperative blood loss in adult patients having spinal fusion surgery. Anesth Analg 2008;107:1479-86.
22. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999;57:1005-32.
23. Horrow JC, Van Riper DF, Strong MD, et al. The dose response relationship of tranexamic acid. Anesthesiology 1995;82:383-92.
24. Martin K, Wiesner G, Breuer T, et al. The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients. Anesth Analg 2008;107:1783-90.